Advisory Services Network’s Gyre Therapeutics GYRE Stock Holding History

Advisory Services Network’s Portfolio GYRE Stock Details GYRE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-66	Closed	-$460	–	3231
2026 Q1	$460	Buy	+66	New	+$513	﹤0.01%	4438
2025 Q4	–	Sell	-66	Closed	-$492	–	2856
2025 Q3	$492	Buy	+66	New	+$501	﹤0.01%	4057
2024 Q1	–	Sell	-66	Closed	-$1.7K	–	2374
2023 Q4	$1.7K	Buy	+66	New	+$936	﹤0.01%	3430
2023 Q2	–	Sell	-67	Closed	-$207	–	2360
2023 Q1	$207	Sell	67 -66	-50%	-$251	﹤0.01%	3838
2022 Q4	$528	Buy	+133	New	+$543	﹤0.01%	3731
2021 Q3	–	Sell	-2,627	Closed	-$85K	–	2181
2021 Q2	$85K	Buy	+2,627	New	+$90.2K	﹤0.01%	1704

Other funds holding GYRE

HSG Holding Na, Hong Kong $1.2B AUM 23.01% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

OCA

Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Advisory Services Network's GYRE Position: Q2 2026 in Review

Advisory Services Network sold out of Gyre Therapeutics (GYRE) in Q2 2026, closing a stake of 66 shares — an estimated $460 sold.

Advisory Services Network first reported a position in GYRE in Q2 2021 and held it in 6 quarters. The position peaked at $85K in Q2 2021. 60 funds tracked by Wall St. Rank hold GYRE as of Q2 2026.

Advisory Services Network reported no remaining Gyre Therapeutics position as of Q2 2026 after selling out during the quarter.
Advisory Services Network sold 66 Gyre Therapeutics shares in Q2 2026, an estimated $460.
Advisory Services Network first reported a position in Gyre Therapeutics in Q2 2021 and held it in 6 quarters.
Advisory Services Network's Gyre Therapeutics position peaked at $85K in Q2 2021.
60 funds tracked by Wall St. Rank held Gyre Therapeutics as of Q2 2026.

Based on Advisory Services Network's 13F filing for Q2 2026, filed 12 Aug 2026.